Maternal, placental and cord blood cytokines and the risk of adverse birth outcomes among pregnant women infected with Schistosoma japonicum in the Philippines
2019
Background The objectives of this study were to 1) evaluate the influence of treatment with
praziquantelon the inflammatory milieu in maternal,
placental, and
cord blood, 2) assess the extent to which proinflammatory signatures in
placentaland
cord bloodimpacts birth outcomes, and 3) evaluate the impact of other helminths on the inflammatory micro environment. Methods/Findings This was a secondary analysis of samples from 369 mother-infant pairs participating in a randomized controlled trial of
praziquantelgiven at 12–16 weeks’ gestation. We performed regression analysis to address our study objectives. In maternal peripheral blood, the concentrations of CXCL8, and TNF receptor I and II decreased from 12 to 32 weeks’ gestation, while IL-13 increased.
Praziquanteltreatment did not significantly alter the trajectory of the concentration of any of the cytokines examined. Hookworm infection was associated with elevated
placentalIL-1, CXCL8 and IFN-γ. The risk of
small-for-
gestational ageincreased with elevated IL-6, IL-10, and CXCL8 in
cord blood. The risk of prematurity was increased when
cord bloodsTNFRI and
placentalIL-5 were elevated. Conclusions Our study suggests that fetal cytokines, which may be related to infectious disease exposures, contribute to poor intrauterine growth. Additionally, hookworm infection influences cytokine concentrations at the maternal-fetal interface. Clinical Trial Registry number and website ClinicalTrials.gov (NCT00486863).
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
53
References
6
Citations
NaN
KQI